Abstract
1 Free fractions of diazepam, propranolol and warfarin were determined in 15 male chronic alcoholics in alcohol withdrawal. 2 On admission the mean free fraction of diazepam was 25% above and propranolol 44% below the limits of normal range, while the mean warfarin free fraction was in high normal range. One week later mean free fraction of diazepam declined by 20% while propranolol and warfarin increased by 24% and 19% respectively (P less than 0.05). 3 Propranolol free fraction and alpha 1-AGP concentrations were highly correlated (linear r = -0.83, P less than 0.001). In contrast the sources of variation in diazepam and warfarin free fraction were more complex and less certain. 4 Statistically significant changes of drug free fractions in serum of chronic alcoholics were observed during alcohol withdrawal. The extent and direction of these changes differed for various classes of drugs and their potential causes appear to be quite different. 5 Clinically important changes in drug effect may be present acutely, within the dosing interval, as a result of altered drug binding. These are more likely when the clinical response is closely related to drug concentration and will occur within the dosing interval due to larger fluctuations in free drug concentration, even though the average free drug concentration will remain unchanged. 6 Total drug level changes will be observed during alcohol withdrawal even in absence of detectable changes of drug metabolism.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abel J. G., Sellers E. M., Naranjo C. A., Shaw J., Kadar D., Romach M. K. Inter- and intrasubject variation in diazepam free fraction. Clin Pharmacol Ther. 1979 Aug;26(2):247–255. doi: 10.1002/cpt1979262247. [DOI] [PubMed] [Google Scholar]
- Blaschke T. F. Protein binding and kinetics of drugs in liver diseases. Clin Pharmacokinet. 1977 Jan-Feb;2(1):32–44. doi: 10.2165/00003088-197702010-00003. [DOI] [PubMed] [Google Scholar]
- Borgå O., Piafsky K. M., Nilsen O. G. Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):539–544. [PubMed] [Google Scholar]
- Ehrnebo M., Odar-Cederlöf I. Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients. Eur J Clin Pharmacol. 1975 Aug 14;8(6):445–453. doi: 10.1007/BF00562320. [DOI] [PubMed] [Google Scholar]
- Greenblatt D. J., Sellers E. M., Koch-Weser J. Importance of protein binding for the interpretation of serum or plasma drug concentrations. J Clin Pharmacol. 1982 May-Jun;22(5-6):259–263. doi: 10.1002/j.1552-4604.1982.tb02671.x. [DOI] [PubMed] [Google Scholar]
- LEVINE J. B., ZAK B. AUTOMATED DETERMINATION OF SERUM TOTAL CHOLESTEROL. Clin Chim Acta. 1964 Oct;10:381–384. doi: 10.1016/0009-8981(64)90073-7. [DOI] [PubMed] [Google Scholar]
- Rollason J. G., Pincherle G., Robinson D. Serum gamma glutamyl transpeptidase in relation to alcohol consumption. Clin Chim Acta. 1972 Jun;39(1):75–80. doi: 10.1016/0009-8981(72)90301-4. [DOI] [PubMed] [Google Scholar]
- Romach M. K., Piafsky K. M., Abel J. G., Khouw V., Sellers E. M. Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma. Clin Pharmacol Ther. 1981 Feb;29(2):211–217. doi: 10.1038/clpt.1981.34. [DOI] [PubMed] [Google Scholar]
- Sellers E. M., Holloway M. R. Drug kinetics and alcohol ingestion. Clin Pharmacokinet. 1978 Nov-Dec;3(6):440–452. doi: 10.2165/00003088-197803060-00002. [DOI] [PubMed] [Google Scholar]
- Shaw J. M., Kolesar G. S., Sellers E. M., Kaplan H. L., Sandor P. Development of optimal treatment tactics for alcohol withdrawal. I. Assessment and effectiveness of supportive care. J Clin Psychopharmacol. 1981 Nov;1(6):382–389. doi: 10.1097/00004714-198111000-00006. [DOI] [PubMed] [Google Scholar]
- TROUT D. L., ESTES E. H., Jr, FRIEDBERG S. J. Titration of free fatty acids of plasma: a study of current methods and a new modification. J Lipid Res. 1960 Apr;1:199–202. [PubMed] [Google Scholar]